Texas lawmakers intensify push to rein in health care prices

By AI, Created 12:06 PM UTC, May 27, 2026, /AGP/ – Texas Senate and House committees are holding hearings on rising health care costs as lawmakers advance a bipartisan affordability effort. Texas 2036 says the state can lower prices by improving transparency, competition and accountability in health care markets.

Why it matters: - Health care prices have become a top financial concern for Texans and a drag on family budgets, wages, hiring and long-term growth. - Texas lawmakers in both chambers are now examining market failures that push costs higher, signaling one of the state’s most coordinated affordability efforts in years.

What happened: - The Texas Senate Health and Human Services Committee met May 27, 2026, to examine what is driving rising health care prices. - The Senate panel is chaired by state Sen. Lois Kolkhorst, R-Brenham, and vice chaired by state Sen. Charles Perry, R-Lubbock. - The hearing happened as the House Select Committee on Health Care Affordability held its first hearings. - The House panel is chaired by state Rep. James Frank, R-Wichita Falls, and vice-chaired by state Rep. Toni Rose, D-Dallas. - Both committees are reviewing market factors behind higher prices and considering policy changes meant to put patients at the center of care decisions.

The details: - Texas 2036 says health care prices rise when markets stop working for patients, families and employers. - The organization’s Healthy Markets framework focuses on three traits: informed, competitive and accountable. - Patients, employers and payers need to see prices before care is delivered. - Federal and state price transparency rules have expanded data on paper, but major gaps remain in practice. - Obscure billing practices, especially when hospitals acquire physician practices and bill under hospital identifiers, can raise prices without clear explanation. - Consolidation among hospitals, insurers, physician practices and pharmacy benefit managers has reduced competition across the health system. - Texas has one of the highest shares of residents living in highly concentrated hospital markets among peer states. - When competition declines, prices rise and patients have fewer choices. - Texas health care incentives are misaligned when the people ordering tests, approving treatments and sending bills are not the people paying them. - That structure rewards higher spending instead of better outcomes, leaving families and employers to absorb the costs. - Texas 2036 says the Healthy Markets agenda could guide reforms on hospital pricing, market consolidation, pharmacy benefit manager practices, price transparency and incentive alignment. - The group argues states have powerful tools to improve competition, increase transparency and lower costs.

Between the lines: - The hearings show bipartisan interest in addressing affordability without waiting on federal action. - The focus on market structure suggests lawmakers are looking beyond insurer premiums alone and into how providers, middlemen and billing rules shape total prices. - Texas 2036 is framing the issue as an economic problem as much as a health care problem.

What’s next: - The Senate and House committees are expected to continue gathering testimony and shaping policy recommendations. - Lawmakers could consider fixes aimed at transparency, consolidation, pharmacy benefit manager behavior and payment incentives. - Texas 2036 is pushing to make the state a national model for health care market reform.

The bottom line: - Texas is moving from diagnosis to policy debate on health care affordability, with market competition and transparency emerging as the central levers for change.